Related Experiment Video

Updated: Nov 25, 2025

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

1.9K

TRPML1-Emerging Roles in Cancer

Yiming Yang1, Xingjian Zhai1, Yassine El Hiani1

  • 1Department of Physiology and Biophysics, Dalhousie University Faculty of Medicine, Halifax, NS B3H 4R2, Canada.

Cells
|December 16, 2020
PubMed

Insights

Mucolipin-1 (TRPML1) channels are vital for cell health, but their dysfunction causes disease. This study explores TRPML1

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Oncology

Background:

  • Mucolipin-1 (TRPML1) channels are crucial for lysosomal function and cellular waste removal.
  • TRPML1 defects are linked to lysosomal storage disorders and neurodegenerative conditions.
  • Emerging research suggests TRPML1 plays a role in cancer development and progression.

Purpose of the Study:

  • To review the current understanding of TRPML1 signaling in cancer.
  • To highlight the dual role of TRPML1 in both normal cellular processes and oncogenesis.
  • To explore therapeutic strategies targeting TRPML1 for cancer treatment.

Main Methods:

  • Literature review of existing studies on TRPML1.
  • Analysis of TRPML1's role in lysosomal homeostasis and autophagy.
  • Examination of TRPML1's involvement in various cancer types and signaling pathways.

Main Results:

  • TRPML1 dysfunction contributes to lysosomal storage diseases and neurodegeneration.
  • Evidence suggests TRPML1 signaling pathways are differentially regulated in cancer.
  • TRPML1's oncogenic potential is being investigated for therapeutic applications.

Conclusions:

  • TRPML1 is a key regulator of lysosomal function with implications beyond storage diseases.
  • Understanding TRPML1's complex role in cancer is essential for developing novel therapies.
  • Targeting TRPML1 pathways offers a promising avenue for cancer treatment interventions.
Keywords:
TRPML1cancerlysosomesmitochondria

More Related Videos

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

3.0K
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

455

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.1K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.9K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
12.7K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.4K